Home › Funds › Harvest Portfolios Group Inc. › ABT

Harvest Portfolios Group Inc. position in ABT

ABBOTT LABORATORIES · Health Care

Harvest Portfolios Group Inc. reported holding 675,099 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$66.7M, representing 0.84% of its reported portfolio and ranking #39 among its reported holdings. Harvest Portfolios Group Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)675.10K sh
Reported value held$66.72M
Portfolio Weight0.84%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Harvest Portfolios Group Inc.'s ABT position evolved

Harvest Portfolios Group Inc. first disclosed a stake in ABT in Q3 2023 at 506,041 shares (US$49.0M). The position peaked in Q2 2026 at 757,820 shares, worth US$68.8M. Across 13 filings, Harvest Portfolios Group Inc. increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 675,099 shares valued at US$66.7M — a reduction of -82,721 shares quarter over quarter.. Notable position changes include a 30% increase in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 506.04K $49.01M New
Q4 2023 516.99K $56.91M Add
Q1 2024 465.02K $52.85M Reduce
Q2 2024 488.47K $50.76M Add
Q3 2024 527.13K $60.10M Add
Q4 2024 453.78K $51.33M Reduce
Q1 2025 439.00K $58.23M Reduce
Q2 2025 432.12K $58.77M Reduce
Q3 2025 456.90K $61.20M Add
Q4 2025 481.46K $60.32M Add
Q1 2026 623.73K $64.04M Add
Q2 2026 757.82K $68.76M Add
Q3 2026 675.10K $66.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Harvest Portfolios Group Inc. held ABT?

Harvest Portfolios Group Inc. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Harvest Portfolios Group Inc.'s current position in ABT?

As of Q3 2026, Harvest Portfolios Group Inc. holds 675.10K shares of ABT (ABBOTT LABORATORIES), valued at $66.72M, representing 0.84% of its reported portfolio and ranking #39.

Has Harvest Portfolios Group Inc. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Harvest Portfolios Group Inc. reduced its position in ABT. The position peaked in Q2 2026 at 757.82K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.